Allogeneic stem cell transplantation for the non-Hodgkin’s lymphomas and Hodgkin’s disease-Reference-Cited by-同舟云学术

Allogeneic stem cell transplantation for the non-Hodgkin’s lymphomas and Hodgkin’s disease

Published:2000-12 Issue:6 Volume:26 Page:411-427
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Hale G.A.,Phillips G.L.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference133 articles.

1. Bone marrow transplantation for non-Hodgkin’s lymphoma: a review;Salzman;Am J Med Sci,1997

2. Intensive therapy and autotransplantation in Hodgkin’s disease;Reece;Stem Cells (Dayt),1994

3. Dose: a critical factor in cancer chemotherapy;Frei;Am J Med,1980

4. Graft-versus-leukemia reactions after bone marrow transplantation;Horowitz;Blood,1990

5. Preparative regimens for patients with leukemias and severe aplastic anemia (overview): biologic basis, experimental animal studies, and clinical trials at the Fred Hutchinson Cancer Research Center;Storb;Bone Marrow Transplant,1994

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validación de la escala FACT-Lym para la evaluación de la calidad de vida en pacientes colombianos con linfoma;Revista de la Facultad de Medicina;2020-07-01

2. The Development and Validation of a Measure of Health-Related Quality of Life for Non-Hodgkin’s Lymphoma: The Functional Assessment of Cancer Therapy—Lymphoma (FACT-Lym);Lymphoma;2013-02-20

3. High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantation;Bone Marrow Transplantation;2007-03

4. Tumors of the Mediastinum;Chest;2005-10

5. The value of augmented preparative regimens combined with an autologous bone marrow transplant for the management of relapsed or refractory hodgkin disease: A southwest oncology group phase II trial;Biology of Blood and Marrow Transplantation;2003-08